DRG Financing System Presents Uncertainties For Healthcare Sector
DRG Financing System Presents Uncertainties For Healthcare Sector
RHB Research emphasised that DRG is not a price-capping mechanism but a discipline-focused approach aimed at improving efficiency and medical outcomes. The research house believes that the system could benefit both hospitals, by optimising resources and patients, through better care delivery.RHB Investment Bank Bhd (RHB Research) has maintained its OVERWEIGHT call on the healthcare sector, identifying IHH Healthcare as its top pick due to its diversified asset base, which positions it well to navigate regulatory uncertainties.
RhB Investment Bank Bhd（RhB Research）維持了對醫療保健行業的增持看漲期權，將IHH Healthcare確定爲其首選，因爲其多元化的資產基礎使其能夠很好地應對監管的不確定性。
The research house highlighted that the recent introduction of a diagnosis-related group (DRG) financing system in Malaysia is expected to benefit hospitals and patients in the long term by streamlining procedures and enhancing resource allocation. However, RHB Research noted that the system also introduces short-term uncertainties regarding its implementation extent.
該研究機構強調，馬來西亞最近推出的診斷相關團體（DRG）融資體系預計將通過簡化程序和加強資源分配，使醫院和患者長期受益。但是，RhB Research指出，該系統的實施程度也帶來了短期的不確定性。
The research house mentioned that while the DRG system moves away from the traditional fee-for-service model by specifying a fixed payment amount based on the complexity of a case, the transition to the DRG system requires extensive study and stakeholder engagement due to the varying complexities and costs of medical procedures.
該研究機構提到，儘管DRG系統通過根據病例的複雜性指定固定付款金額來擺脫傳統的收費服務模式，但由於醫療程序的複雜性和成本各不相同，向DRG系統的過渡需要廣泛的研究和利益相關者的參與。
RHB Research emphasised that DRG is not a price-capping mechanism but a discipline-focused approach aimed at improving efficiency and medical outcomes. The research house believes that the system could benefit both hospitals, by optimising resources and patients, through better care delivery.
RhB Research強調，DRG不是一種價格上限機制，而是一種以學科爲重點的方法，旨在提高效率和醫療結果。該研究機構認爲，該系統可以通過優化資源和通過更好的醫療服務使兩家醫院受益，從而使兩家醫院受益。
It also highlighted recent sell-offs in the healthcare sector, attributing them to uncertainties around the DRG implementation. However, RHB Research viewed this as an opportunity for investors to capitalise on attractive entry points, especially for those with a long-term perspective on the structural changes in the industry.
它還強調了醫療保健行業最近的拋售，將其歸因於DRG實施的不確定性。但是，RhB Research認爲這是投資者利用有吸引力的切入點的機會，特別是對於那些從長遠角度看待行業結構性變化的投資者而言。
For investors concerned about potential unfavourable outcomes from the DRG system, RHB Research pointed to Sunway Group as a viable alternative. With diversified exposure across sectors such as data centre construction, property development, and hospitality, Sunway is seen as capable of mitigating any negative impact on its healthcare unit. The healthcare division contributed 14.5% of the group's profit before tax for the first nine months of 2024 and 34% of RHB Research's estimated restated net asset value.
對於擔心DRG體系潛在不利結果的投資者，RhB Research指出，信威集團是一個可行的替代方案。憑藉數據中心建設、房地產開發和酒店業等領域的多元化投資機會，Sunway被認爲能夠減輕其醫療保健部門的任何負面影響。該醫療保健部門在2024年前九個月貢獻了該集團稅前利潤的14.5％，佔RhB Research估計的重報淨資產價值的34％。
譯文內容由第三人軟體翻譯。